PARALISIS SUPRANUCLEAR PROGRESIVA PDF

adminComment(0)

Information on Paralisis Supranuclear Progresiva/Spanish-language fact sheet on Progressive Supranuclear Palsy. Compiled by the National Institute of. Caracteristicas clinicas de la Paralisis supranuclear progresiva en el INCN. Article (PDF Available) · October with 79 Reads. La parálisis supranuclear progresiva clásica, también conocida como síndrome de Richardson, es la variante por la inestabilidad postural, rigidez progresiva, parálisis visual supranuclear y demencia leve. Resumen; Greek (, pdf).


Paralisis Supranuclear Progresiva Pdf

Author:RASHAD KREWER
Language:English, Arabic, Portuguese
Country:Palau
Genre:Politics & Laws
Pages:513
Published (Last):14.04.2016
ISBN:205-3-63316-712-1
ePub File Size:18.66 MB
PDF File Size:13.23 MB
Distribution:Free* [*Registration Required]
Downloads:34445
Uploaded by: EDYTHE

El diagnóstico etiológico fue: parálisis supranuclear progresiva y cardiomiopatía . usion_en_el_cuidador/links/kaz-news.info 6- Ling H, de. Shy-Drager, la Parálisis Supranuclear Progresiva y la Atrofia. Multisistémica. Los estudios investigativos en curso están evaluando los efectos del LSVT en la. Balcells Riba M., Jubert Gruart J., Espadaler Medina J.M.:Parálisis supranuclear progresiva o distonia oculo-facio-cervical. Estúdio de un caso clínico.

Brain, 98, —, Paris , , —, Google Scholar [26] Brusa A. Paris, 43, —, Nuclear ophthalmoplegia, with especial reference to retraction of the lids and ptosis and to lesions of the posterior commissure. Brain, 50, —, Google Scholar [30] Cambier J. A propos d'une observation anatomo-clinique.

Progressive supranuclear palsy

Google Scholar [31] Cambier J. A propos d'une observation. Google Scholar [38] Corin M. Sinai J. Google Scholar [41] Couet P.

Google Scholar [42] Craus A. Google Scholar [43] Critchley M. Brain, 52, 23—83, Google Scholar [45] Curzon G. Poor response to therapy may be the first clue. Geriatrics, 7, 60—61, Google Scholar [47] Dalziel J. Age Ageing, 6, —, Atti XXI Cong. Google Scholar [50] Dehaene I. Lancet, ii, , Acta Neurol. Google Scholar [53] Dix M. A report of 9 cases with particular reference to the mechanism of the oculomotor disorder. Mac G. Google Scholar [56] Evrard E. S Goldensohn, S. Appel,Scientific Approaches to Clinical Neurology.

Google Scholar [58] Ferri E. Minerva Med. The effects of section of one or both vestibular nerves. Hopkins Hosp.

Google Scholar [61] Freund C. Gesamte Neurol.

Learn More

Google Scholar [64] Gimenez-Roldan S. Lancet, ii, —, Google Scholar [67] Gross R.

Practitioner ed. Google Scholar [69] Iijima M. Diagnosis Ther. In Japanese. El objetivo del tratamiento es lograr la mayor respuesta a la L-Dopa, esto es, la dosis que permita al paciente una vida activa, que incluya el ejercicio. Aumentar la dosis en ese momento no produce mayor beneficio; en cambio pueden redistribuirse la dosis y acercarse las tomas.

En este caso es prudente adicionar al tratamiento la amantadina. Pramipexol El pramipexol es un agonista de la dopamina con afinidad por los receptores D2 y D3. Bromocriptina Aunque la bromocriptina tiende a producir menos efectos colaterales a nivel motor, muchos pacientes abandonan el tratamiento debido a estos efectos o a falta de respuesta al tratamiento.

Cuando se ha utilizado la bromocriptina combinada con la L-Dopa no parece prevenir ni retrasar las complicaciones motoras. Sus presentaciones respectivas son 5mg, y 2 y 4mg.

Procedimientos lesionales. Neurology and neurosurgery. En: Levenson JL ed. Textbook of psychosomatic medicine.

Psychiatric care of the medically ill. Washington: APPI; Lerner AJ, Riley D.

paralisis supranuclear progresiva pdf

Neuropsychiatric aspects of dementias associated with motor dysfunction. The American psychiatric publishing textbook of neuropsychiatry and behavioral sciences. Arlington: APPI; Parkinson J. An essay on the shaking palsy. J Neuropsychiatry Clin Neurosci ; Goetz CG.

Charcot on Parkinson's disease. Mov Disord ;1 1 Neurology ;69 5 Louis ED. The shaking palsy, the first forty-five years: a journey through the British literature. Mov Disord ;12 6 Lees AJ. Unresolved issues relating to the shaking palsy on the celebration of James Parkinson's th birthday. Mov Disord ;22 Supl 17 :ss Parent M, Parent A. Substantia nigra and Parkinson's disease: a brief history of their long and intimate relationship.

Can J Neurol Sci ;37 3 Marsh L, Margolis RL. Neuropsychiatric aspects of movement disorders. En: Kaplan, Sadock's eds. Comprehensive textbook of psychiatry. Epidemiological and genetic aspects of neuropsychiatric disorders. Risk of Parkinson disease onset in patients with diabetes. A 9- year population- based cohort study with age and sex stratifications.

Diabetes ; Basal ganglia-thalamocortical circuits : Parallel substrates for motor, oculomotor, prefrontal and limbic functions. Prog Brain Res ; Pakinsonism: onset, progression, and mortality.

Neurology ; Fahn S, Elton R.

Accesada el 12 de abril de Mov Disord 15 Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol ; Urinary dysfunction in early and untreated Parkinson's disease. J Neurol Neurosurg Psychiatry ; Ahlskog JE.

Progressive supranuclear palsy an overview

Cheaper, simpler, and better: Tips for treating seniors with Parkinson disease. Mayo Clin Proc ;86 12 Ann Neurol ;54 1 Parkinson Study Group.Louis ED. Putaminal pigments and nosology. Surgical treatment of Parkinson's disease consists of ablative procedures and deep brain stimulation. Alteraciones del tono muscular. Diabetes ; Schapira A. Case reports of rehabilitation programs for patients with PSP generally include limb-coordination activities, tilt-board balancing, gait training , strength training with progressive resistive exercises, and isokinetic exercises and stretching of the neck muscles.

Download to read the full article text References [1] Agostini L.

Drugs ;71 3 Risk of Parkinson disease onset in patients with diabetes.